Newron and Myung In Pharm have signed a licence agreement for evenamide, for schizophrenia treatment in South Korea.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback